First batch of COVID-19 vaccine reaches Srinagar

Srinagar: The first batch of COVID-19 vaccines reached Srinagar Wednesday afternoon with officials saying that the first dose will be given to health care workers.

“Today, we received our 1st batch of Covid-19 vaccine and vaccination will be started on 16 January across the country for which department has already done groundwork and mock drills,” officials said.

State Immunisation Officer Dr Qazi Haroon said that they received first batch of vaccines in Srinagar on Wednesday afternoon and accordingly they will be forwarded to different areas so that vaccination drive can begin along with other states on 16 January.

Qazi said that they have arranged choppers to take vaccines to far off places in J&K like Gurez, Tanghdar Karnah and by Friday they will be all ready to start the vaccination process along with the entire country on Saturday.

Pertinently, the first phase of the vaccination drive will cover 30 crore people in India.

India has authorised two Covid-19 vaccines – indigenous Bharat Biotech’s Covaxin and the Oxford-AstraZeneca & Serum Institute of India vaccine Covishield for emergency use.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre